1. I have taken 23 Israeli companies to NASDAQ starting in 1981 with two healthcare
companies The major benefits are:
An Israeli NASDAQ company gets important marketing mindshare. Its
fortunes are closely followed--with proper IR.
the ability to raise further large financings.
Clearly not every Israeli healthcare company can or should do an IPO. It is very
expensive and time consuming. The major requirements are:
1. Having the mindset to be public in the USA, willingness to make IR a
material part of the CEO and CFO's efforts;
2. Having a clearly innovative large-market product/platform/pipeline that is
immediately appealing in a one sentence sell.
3. Being late stage enough, Phase 2/3 clinical trials with revenue in sight, and
the validation of a large strategic partner.
4. A USA office.
Before the IPO, to maximize reward and minimize risk:
Prepare/rehearse a dynamite presentation;
Do market research by doing an initial road show to relevant IPO
underwriters; ask can my company go public? will it be a viable IPO? What
do I have to do? Consult for advice.
Hire attorneys on semi-contingency.
Only then undertake the arduous, long, costly, fun (with the proper attitude) fund
raising process.